1 September 1992 Transurethral microwave hyperthermia in benign prostatic hyperplasia
Author Affiliations +
Optical Engineering, 31(9), (1992). doi:10.1117/12.59906
Abstract
Benign prostatic hyperplasia (BPH) is a common disease affecting past middle-aged males. Surgical treatment has been successfully used since the early 1900s. Currently, nonsurgical treatment modalities are under intensive study in BPH patients who have relative contraindications to surgery. Transurethral microwave hyperthermia (TUHT) is one of these modalities under study. TUHT has been applied in five to ten treatment sessions. The treatments were well tolerated with no major toxicity being reported. In BPH patients with predominance of median lobe or median bar enlargement the treatment efficacy was reduced to 30%. The effectiveness of TUHT was of particular importance in patients who had urinary retention. In this group 72% had normal voiding for 12 months or longer. A strong correlation between applied temperature and response to treatment was demonstrated. Current efforts are directed toward optimization of technique and treatment schedule. A phase III prospective randomized trial is required to define the role of TUHT in the management of BPH patients.
Zbigniew P. Petrovich, Filip Ameye, Luc Baert, "Transurethral microwave hyperthermia in benign prostatic hyperplasia," Optical Engineering 31(9), (1 September 1992). http://dx.doi.org/10.1117/12.59906
JOURNAL ARTICLE
5 PAGES


SHARE
KEYWORDS
Prostate

Antennas

Microwave radiation

Surgery

Toxicity

Therapeutics

Tissues

Back to Top